InflaRx (IFRX) Change in Working Capital (2017 - 2020)
InflaRx's (IFRX) quarterly Change in Working Capital came in at $4.5 million in Q4 2020, up 70.03% year-on-year from $2.6 million in Q1 2020, and up 70.03% quarter-over-quarter from $2.6 million in Q4 2019.
InflaRx (IFRX) Change in Working Capital (2017 - 2020) Analysis & Trends
InflaRx has disclosed Change in Working Capital across 4 years of filings, most recently posting $4.5 million for Q4 2020.
- Change in Working Capital for Q4 2020 came in at $4.5 million, up 70.03% year-over-year; the trailing twelve-month figure through Dec 2020 was $4.5 million (up 70.03% YoY), and the FY2024 annual result was $5.5 million, up 25.56% from the prior year.
- Change in Working Capital came in at $4.5 million for Q4 2020 at InflaRx, up from $2.6 million in the prior quarter.
- In the past five years, Change in Working Capital ranged from a high of $4.5 million in Q4 2020 to a low of $189757.7 in Q2 2018.
- The 4-year median for Change in Working Capital is $1.4 million (2017), against an average of $1.9 million.
- Peak annual rise in Change in Working Capital reached 70.03% in 2020, while the deepest fall reached 70.03% in 2020.
- InflaRx's Change in Working Capital stood at $227244.5 in 2017, then decreased by 16.5% to $189757.7 in 2018, then surged by 1280.08% to $2.6 million in 2019, then jumped by 70.03% to $4.5 million in 2020.
- The last three Change in Working Capital figures came in at $4.5 million (Q4 2020), $2.6 million (Q4 2019), and $189757.7 (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.45 Mn |
| Dec 31, 2020 | 4.45 Mn |
| Dec 31, 2019 | 2.62 Mn |
| Dec 31, 2019 | 2.62 Mn |
| Jun 30, 2018 | 189,757.66 |
| Jun 30, 2018 | 189,757.66 |
| Dec 31, 2017 | 227,244.48 |
| Dec 31, 2017 | 227,244.48 |